deprakine 300 mg enterotabletter
sanofi a/s - natriumvalproat - enterotabletter - 300 mg
deprakine retard 300 mg depottabletter
sanofi a/s - natriumvalproat, valproinsyre - depottabletter - 300 mg
deprakine 500 mg enterotabletter
sanofi a/s - natriumvalproat - enterotabletter - 500 mg
deprakine retard 500 mg depottabletter
sanofi a/s - natriumvalproat, valproinsyre - depottabletter - 500 mg
nuedexta
jenson pharmaceutical services limited - dextromethorphan, quinidin - neurobehavioral manifestations - andre narkotika stoffer - nuedexta er indiceret til symptomatisk behandling af pseudobulbar påvirkning (pba) hos voksne. effekt er kun undersøgt hos patienter med underliggende amyotrofisk lateralsklerose eller multipel sklerose.
depakine retard 500 mg depottabletter
2care4 aps - natriumvalproat, valproinsyre - depottabletter - 500 mg
pivmecillinamhydrochlorid "karo pharma" 400 mg filmovertrukne tabletter
karo pharma ab - pivmecillinamhydrochlorid - filmovertrukne tabletter - 400 mg
depakine chrono 500 mg depottabletter
orifarm a/s - natriumvalproat, valproinsyre - depottabletter - 500 mg
escitalopram "bluefish" 10 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - escitalopramoxalat - filmovertrukne tabletter - 10 mg
escitalopram "bluefish" 15 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - escitalopramoxalat - filmovertrukne tabletter - 15 mg